Adult B-Cell Precursor Acute Lymphoblastic Leukemia (BC-ALL) Negative For Recurrent Fusion Genes Are Characterized By a High Complex Genetic Heterogeneity Influencing Prognosis
Ilaria Iacobucci(St. Jude Children's Research Hospital), Giovanni Martinelli(University of Bologna), Roberta Zuntini(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Robin Foà(Sapienza University of Rome), Valentina Robustelli(University of Bologna), Simona Soverini(University of Bologna), Anna Ferrari(University of Bologna), Andrea Ghelli Luserna di Rorà(Fondazione Pisa), Chiara Sartor(University of Bologna), Maria Chiara Abbenante(University of Bologna), Emanuela Ottaviani(University of Bologna), Annalisa Lonetti(University of Bologna), Domenico Russo(University of Brescia), Barbara Giannini(Azienda Unità Sanitaria Locale Della Romagna), Sabina Chiaretti(Sapienza University of Rome), Sarah Parisi(University of Bologna), Cristina Papayannidis(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Margherita Perricone(University of Bologna), Nicoletta Testoni(Thrombolysis in Myocardial Infarction Study Group), Federica Cattina(University of Brescia), Viviana Guadagnuolo(University of Bologna), Carmen Baldazzi(University of Bologna), Claudia Venturi(University of Bologna), Antonella Vitale(University of the Sacred Heart), Stefania Paolini(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Loredana Elia(Sapienza University of Rome), Alexander Kohlmann
Cited by 3
Related Papers
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
|Blood|2015|1.2k
Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia
|New England Journal of Medicine|2005|644